Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Shentracon Chemicals Ltd

SHENTRA
BSE
79.92
4.99%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Shentracon Chemicals Ltd

SHENTRA
BSE
79.92
4.99%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
35Cr
Close
Close Price
79.92
Industry
Industry
Chemicals - Inorganic
PE
Price To Earnings
PS
Price To Sales
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
762.50%
Peer Comparison
How does SHENTRA stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SHENTRA
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-40.00.00.0-200.028.6-400.0-100.0233.3-440.0240.0-2,300.0-125.0
NPM
NPM%
EPS
EPS
-0.20.00.0-0.1-0.1-0.1-0.10.1-0.60.2-1.10.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
000000000000
Growth
Revenue Growth%
Expenses
ExpensesCr
000003000000
Operating Profit
Operating ProfitCr
00000-3000000
OPM
OPM%
Other Income
Other IncomeCr
000003000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
00000000000-1
Growth
PAT Growth%
-100.0-1,22,989.0100.2182.231.968.5-45.5-36.3-9.2-179.5-130.8
NPM
NPM%
EPS
EPS
0.0-0.10.00.0-0.5-0.3-0.1-0.2-0.2-0.2-0.7-1.6

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
-5-5-5-5-6-6-6-6-6-6-6-7
Current Liabilities
Current LiabilitiesCr
200000000000
Non Current Liabilities
Non Current LiabilitiesCr
022253333333
Total Liabilities
Total LiabilitiesCr
444442222111
Current Assets
Current AssetsCr
333312002011
Non Current Assets
Non Current AssetsCr
111130110100
Total Assets
Total AssetsCr
444442222111

Cash Flow

Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
00000-300-21-2
Investing Cash Flow
Investing Cash FlowCr
000007-101-11
Financing Cash Flow
Financing Cash FlowCr
00000-200000
Net Cash Flow
Net Cash FlowCr
000002-10000
Free Cash Flow
Free Cash FlowCr
00000400-21-2
CFO To PAT
CFO To PAT%
61,028.1564.5-14,756.515,914.081.61,611.9153.6101.11,576.8-1,214.0517.4
CFO To EBITDA
CFO To EBITDA%
-101.284.119.6-119.199.476.3102.8101.01,404.3-1,292.0957.4

Ratios

Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
00000000000
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.00.00.00.00.0
Price To Sales
Price To Sales
Price To Book
Price To Book
0.00.00.00.00.00.00.00.00.00.00.0
EV To EBITDA
EV To EBITDA
-95.5-7.0-25.9-50.8-15.9-0.3-35.8-38.6-26.0-28.0-20.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
NPM
NPM%
ROCE
ROCE%
0.0-2.31.21.2-10.8-8.8-3.4-5.1-6.8-8.3-21.1
ROE
ROE%
0.05.40.00.020.212.13.75.16.56.615.5
ROA
ROA%
0.0-1.10.00.0-5.6-9.4-3.2-4.8-6.5-7.7-20.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
**Shentracon Chemicals Limited** (BSE: **530757**; CSE: **29095**) is an Indian industrial entity currently undergoing a comprehensive structural and operational transformation. After a **10-year period of dormancy**, the company is transitioning from a legacy of financial distress and regulatory suspension toward a revival phase under new promoter leadership. This profile details the company’s transition from a manufacturer of chromium-based chemicals to a revitalized corporate vehicle focused on trading and contract manufacturing. --- ### **I. Strategic Pivot: Ownership Transition and Management Control** Following a **Share Purchase Agreement (SPA)** dated **September 04, 2025**, Shentracon Chemicals has undergone a change in management control. The company is being steered by a new promoter group with the intent to leverage the listed entity for new business opportunities. * **New Promoter Group (The Acquirers):** **Mr. Amit Lalit Jain** (Managing Director) and **Mr. Hanissh Kanakraj Jaain** (Executive Director). * **Acquisition Stake:** The Acquirers secured **23,17,343 equity shares (52.21%)** via the SPA. * **Open Offer Status:** A mandatory Open Offer was launched for an additional **11,53,917 shares (26.00%)** at an offer price of **₹ 0.50 per share**. * **Post-Offer Ownership:** Upon full acceptance, the new promoter holding could reach **78.21%**. * **Board Reconstitution:** Completed on **October 24, 2025**, to reflect the new leadership. * **Strategic Relocation:** In **March 2026**, the Board approved a new **Corporate Office in Mumbai** and shifted the **Registered Office** within Kolkata to modernize administrative functions. --- ### **II. Operational Status and Revival Roadmap** Historically, the company was a specialized manufacturer in the chemical sector. While the factory was previously closed and fixed assets disposed of, the new management is focused on a phased revival. **Legacy Manufacturing Competencies:** * **Core Products:** Sodium Dichromate, Basic Chrome Sulphate, Sodium Sulphate Anhydrous, and Chrome Oxide Green. * **Technology:** Rotary batch oil-fired technology. * **Specialized Projects:** A unique project for **Chromium Metal** production via an exothermic process, noted as a pioneer for the Indian market. **Current Business Model:** * **Segment Focus:** Currently restricted to a single segment: **"Selling of chemical products"** within **India**. * **Revival Pillars:** The strategy involves transitioning from idle manufacturing to **chemical trading** and **contract-based manufacturing**. * **Inorganic Growth:** Management is actively assessing potential collaborations, technology partnerships, and acquisitions to accelerate the return to revenue generation. --- ### **III. Financial Restructuring and Capital Base** The company has executed a significant overhaul of its capital structure to clear legacy obligations and prepare for fresh investment. **Capital Structure Summary (as of March 31, 2025):** * **Paid-up Equity Capital:** **₹ 4,43,81,430**. * **Preference Capital Overhaul:** The authorized preference capital was reclassified into **19,00,000 Cumulative Non-Convertible Redeemable Preference Shares (CNCRPS)**. **Key Financial Actions:** | Action | Details | | :--- | :--- | | **Legacy Redemption** | Premature redemption of **3,44,743 10% CCRPS** (at **₹ 53/share**) and **10,00,000 13.5% CRPS** (at **₹ 12/share**). | | **Fresh Issuance** | Allotment of **6,06,000 10% CNCRPS** of **₹ 50** each via private placement (March 2025). | | **NCRPS Terms** | **10% coupon** (compounded annually); **20-year** redemption period; redemption at **₹ 50** or **Fair Price**, whichever is higher. | **Historical Performance (Pre-Revival):** | Metric | FY 2022-23 | FY 2021-22 | | :--- | :--- | :--- | | **Total Income** | **₹ 1,71,150** | **₹ 976** | | **Net Profit / (Loss)** | **₹ (9,79,538)** | **₹ (7,18,528)** | | **Dividend** | **Nil** | **Nil** | --- ### **IV. Regulatory Standing and Listing Status** A primary achievement of the new management has been the restoration of the company’s regulatory standing after years of non-compliance. * **BSE Listing:** Trading suspension was revoked; shares resumed trading on **August 19, 2025**, under the **'P' Group**. * **CSE Listing:** The Board has approved **delisting from the Calcutta Stock Exchange (CSE)** to streamline costs, while maintaining the primary listing on the **BSE**. * **Compliance Infrastructure:** Connectivity established with **NSDL and CDSL**; financial reporting is now compliant with **Ind AS**. * **Internal Governance:** Re-established the **Audit Committee**, **Nomination and Remuneration Committee**, and **Stakeholders’ Relationship Committee**. --- ### **V. Critical Risk Factors and Investment Considerations** **1. Financial Fragility and Going Concern** The company’s **net worth is fully eroded** due to accumulated losses. Auditors continue to highlight material uncertainty regarding the company's ability to continue as a **"Going Concern."** There has been no meaningful revenue for **10 consecutive years**. **2. Management Experience Gap** The new Acquirers possess over **15 years of experience** in the **imitation jewellery** sector but lack a direct track record in **chemical manufacturing or trading**. The success of the revival depends on their ability to navigate a technically complex industry. **3. Minimum Public Shareholding (MPS) Compliance** If the Open Offer results in a promoter stake of **78.21%**, the company will breach the **25% Minimum Public Shareholding** requirement. Under **Rule 19A of the SCRR**, the company will be required to divest the excess stake to remain compliant. **4. Legacy Promoter and Liquidity Issues** * **Untraceable Holdings:** **4,00,000 shares** held by the former promoter, **Shentracon Financial Services Ltd (SFSL)**, remain in physical mode and are under lock-in due to a lack of KYC and contact. * **Trading Liquidity:** Shares are classified as **"infrequently traded"** under SEBI (SAST) Regulations, posing exit risks for minority investors. **5. Liability Obligations** The company carries long-term financial liabilities and significant **dividend arrears** on legacy preference shares (dating back to **1995**) that remain unpaid due to the lack of distributable profits.